₹2,449.9
▲ +54.14 +2.26%
29 Jul 2026
NSE Listed · Pharmaceuticals
Lupin Limited (LUPIN)
Volume: 4,69,950Avg Vol 1W: 7,33,347Avg Vol 1M: 7,64,59552W Range:₹1,836.8₹2,529.5
Key Ratios
Checked 2h agoMarket Cap₹1,11,844 Cr
Current Price₹2,449.9
Previous Close₹2,395.76
High / Low (52w)₹2,529.5 / ₹1,836.8
Volume4,69,950
Avg Vol (1W)7,33,347
Avg Vol (1M)7,64,595
Stock P/E70.23
Book Value₹490.99
Dividend Yield0.79%
ROE23.76%
ROA13.96%
Revenue (TTM)—
Revenue Growth13.48%
Profit Margin19.4%
Total Debt₹1,766 Cr
Shares Outstanding46 Cr
Face Value₹2
EPS (TTM)₹34.83
P/B4.98
Debt / Equity0.29
50 DMA₹2,362.38
200 DMA₹2,220.37
Day change+2.26%
Price Chart
₹2,449.9▲ 23.45% · 1Y
2025-07-292026-07-29
20-day avg volume: 7.5L shares
Pros
- Healthy return on equity of 23.8%.
- Company is almost debt-free.
- Revenue grew 455% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 70.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹5,600 Cr | ₹5,673 Cr | ₹5,768 Cr | ₹5,667 Cr | ₹6,268 Cr | ₹7,048 Cr | ₹7,168 Cr | ₹7,475 Cr |
| EBITDA | ₹1,061 Cr | ₹1,126 Cr | ₹1,138 Cr | ₹985 Cr | ₹1,507 Cr | ₹2,115 Cr | ₹2,064 Cr | ₹2,180 Cr |
| Net Profit | ₹801 Cr | ₹853 Cr | ₹855 Cr | ₹773 Cr | ₹1,219 Cr | ₹1,478 Cr | ₹1,176 Cr | ₹1,460 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4,208 Cr | ₹22,910 Cr | ₹4,486 Cr | ₹5,709 Cr | ₹4,068 Cr | ₹4,501 Cr | ₹29,039 Cr | ₹5,235 Cr |
| EBITDA | ₹1,314 Cr | ₹4,310 Cr | ₹1,587 Cr | ₹2,607 Cr | ₹1,071 Cr | ₹1,538 Cr | ₹7,865 Cr | ₹2,193 Cr |
| Net Profit | ₹985 Cr | ₹3,282 Cr | ₹1,291 Cr | ₹2,128 Cr | ₹1,357 Cr | ₹717 Cr | ₹5,333 Cr | ₹2,164 Cr |
| EPS | — | 71.69 | — | — | — | — | 116.44 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹27,949 Cr | ₹24,984 Cr | ₹23,610 Cr | ₹21,821 Cr | ₹22,956 Cr | ₹23,997 Cr | ₹29,205 Cr | ₹38,365 Cr |
| Total Liabilities | ₹14,160 Cr | ₹12,403 Cr | ₹9,752 Cr | ₹9,599 Cr | ₹10,413 Cr | ₹9,624 Cr | ₹11,911 Cr | ₹15,851 Cr |
| Equity | ₹13,789 Cr | ₹12,581 Cr | ₹13,858 Cr | ₹12,222 Cr | ₹12,543 Cr | ₹14,373 Cr | ₹17,294 Cr | ₹22,513 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹2,605 Cr | ₹1,980 Cr | ₹2,537 Cr | ₹320 Cr | ₹2,140 Cr | ₹3,974 Cr | ₹3,906 Cr | ₹8,602 Cr |
| Investing | ₹-3,282 Cr | ₹1,107 Cr | ₹-1,240 Cr | ₹1,292 Cr | ₹-1,287 Cr | ₹-1,712 Cr | ₹-4,172 Cr | ₹-3,865 Cr |
| Financing | ₹744 Cr | ₹-891 Cr | ₹-1,885 Cr | ₹-1,572 Cr | ₹-337 Cr | ₹-2,184 Cr | ₹1,732 Cr | ₹-846 Cr |
| Free Cash Flow | ₹1,620 Cr | ₹1,307 Cr | ₹1,860 Cr | ₹-585 Cr | ₹2,140 Cr | ₹3,974 Cr | ₹3,906 Cr | ₹8,602 Cr |
Shareholding
Promoter 46.85% Institutions 47.07% Public 6.08%
Efficiency & Working Capital
ROCE21.3%
Interest Coverage16.8
Dividend Payout—
Debtor Days86 d
Inventory Days79 d
Payable Days54 d
Cash Conversion Cycle111 d
Working Capital Days166 d
Shareholding Details
As of 2026-06-30
Promoter46.8%
FII22.4%
DII24.6%
Institutions47.1%
Public6.1%
Promoter Pledge0%
No. of Shareholders3,00,283
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 47.1% | 47% | 47% | 47% | 47% | 47% | 46.9% | 46.9% | 46.9% | 46.9% | 46.9% | 46.8% |
| FIIs | 15% | 16.1% | 18.3% | 19.3% | 21.5% | 22% | 21.5% | 21.3% | 20.5% | 21.5% | 21.7% | 22.4% |
| DIIs | 29.4% | 29.7% | 27.8% | 26.8% | 25.1% | 24.7% | 25.4% | 25.6% | 26.5% | 25.6% | 25.3% | 24.6% |
| Public | 8.5% | 7.1% | 6.9% | 6.9% | 6.4% | 6.3% | 6.2% | 6.3% | 6.1% | 6% | 6.1% | 6.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,89,074 | 2,81,542 | 2,80,248 | 2,88,537 | 2,79,280 | 2,81,988 | 2,83,210 | 2,86,604 | 2,80,256 | 2,88,931 | 2,90,411 | 3,00,283 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Lupin Investments Private Limited | Shareholding of Promoter and Promoter Group | 45.3% | 20.72 Cr |
| Hdfc Trustee Company Ltd. A/c Hdfc Balanced Advantage Fund | Public Shareholding | 4.4% | 2.00 Cr |
| Life Insurance Corporation Of India | Public Shareholding | 4.1% | 1.87 Cr |
| Nps Trust- A/c Hdfc Pension Fund Management Limited Scheme E - Tier I | Public Shareholding | 2.8% | 1.26 Cr |
| Nippon Life India Trustee Ltd- A/c Nippon India Growth Mid Cap Fund | Public Shareholding | 2.6% | 1.19 Cr |
| Sbi Elss Tax Saver Fund | Public Shareholding | 2% | 89,58,810 |
| Mirae Asset Large & Midcap Fund | Public Shareholding | 1.7% | 79,65,880 |
| Hdfc Life Insurance Company Limited | Public Shareholding | 1.1% | 50,08,992 |
| Manju D Gupta | Shareholding of Promoter and Promoter Group | 0.9% | 38,71,162 |
| Nilesh Gupta | Shareholding of Promoter and Promoter Group | 0.2% | 9,01,064 |
| Anuja Gupta | Shareholding of Promoter and Promoter Group | 0.2% | 7,25,705 |
| D B Gupta Huf (nilesh Deshbandhu Gupta, Karta Of Huf) | Shareholding of Promoter and Promoter Group | 0.1% | 6,47,580 |
| Vinita Gupta | Shareholding of Promoter and Promoter Group | 0.1% | 3,27,424 |
| Richa Gupta | Shareholding of Promoter and Promoter Group | 0.1% | 2,33,265 |
| Kavita Gupta | Shareholding of Promoter and Promoter Group | 0% | 2,00,170 |
| Veda Nilesh Gupta | Shareholding of Promoter and Promoter Group | 0% | 77,104 |
| Neel Deshbandhu Gupta | Shareholding of Promoter and Promoter Group | 0% | 32,068 |
| Shefali Nath Gupta | Shareholding of Promoter and Promoter Group | 0% | 1,752 |
| Manju D Gupta (as A Trustee Of Gupta Family Trust) | Shareholding of Promoter and Promoter Group | 0% | 1,000 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| M D Gupta | Chairman (Non-Executive) | 2025 |
| Nilesh Deshbandhu Gupta. | Managing Director | 2025 |
| Vinita Gupta | Director & Chief Executive Officer | 2025 |
| R V Satam | Company Sec. & Compli. Officer | 2025 |
| Jean-Luc Belingard | Independent Director | 2025 |
| Ramesh Swaminathan | Director & Group CFO | 2025 |
| Mark D McDade | Independent Director | 2025 |
| K B S Anand | Independent Director | 2025 |
| Jeffrey Kindler | Independent Director | 2025 |
| Alfonso Zulueta | Independent Director | 2025 |
| Punita Lal | Independent Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Sale of pharmaceutical goods | ₹18,916 Cr | 99.3% |
| Service income | ₹11 Cr | 0.1% |
| Income from research services and s | ₹118 Cr | 0.6% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹7,822 Cr | 41.1% |
| USA | ₹7,829 Cr | 41.1% |
| Others | ₹3,393 Cr | 17.8% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹2 | 200 | 91 | 91 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-06 | Board Meetings | — |
| forthcoming | 2026-07-17 | Dividend (18/- per share) | Final |
| dividend | 2026-07-17 | ₹18 (900%) | Final |
| dividend | 2025-07-25 | ₹12 (600%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 12,350 | 0 | 0 | 47 | 515 | 13,160 |
| 2026 | 1,748 | 0 | 0 | 0 | 224 | 1,972 |
| 2026 | 934 | 0 | 0 | 47 | 174 | 1,403 |
Insider / Designated-Person Trades
9 recent disclosure(s)
Dr. Kamal K SharmaDisposal · 15,000
Neel Deshbandhu GuptaAcquisition · 2,650
Veda Nilesh GuptaAcquisition · 2,650
Nilesh D. GuptaDisposal · 5,300
Nilesh D. GuptaAcquisition · 5,300
Sunil MakhariaDisposal · 20,000
Company Information
Incorporated1983
ChairmanM D Gupta
AuditorB S R & Co LLP/Deloitte Haskins & Sells LLP
Investor Email[email protected]
📍 Kalpataru Inspire 3rd Floor, Off Western Exp HW Santacruz-E, Mumbai, Maharashtra, 400055
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search